Amgen Inc.
AMGN · Healthcare · · USDFahodi Score HOLD Long-term (Investment)
63
/ 100
Technical
100
Trend & RS
92
Momentum
81
Fundamental
56
Macro
22
Liquidity
70
| Component | Score | Weight |
|---|---|---|
| Technical | 100.0 | 10% |
| Trend & RS | 92.3 | 10% |
| Momentum | 80.9 | 5% |
| Fundamental | 55.6 | 40% |
| Macro | 22.5 | 15% |
| Liquidity | 70.4 | 20% |
Trade Setup
| Entry | 460.28 |
| Stop Loss | 435.16 (5.5%) |
| Target 1 (1:1) | 485.40 (+5.5%) |
| Target 2 (2:1) | 510.52 (+10.9%) |
| ATR(14) | 12.56 (2.7%) |
| Risk per Share | 25.12 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 25.9 | -0.96 | |
| Momentum | 80.9 | +1.23 | |
| Quality | 65.4 | +0.62 | |
| Composite | 57.4 | ||
Quality Scores
Piotroski F-Score
5
/9 —
Average
✓
✓
✗
✗
✗
✗
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 26.7 | 22.0 | +21% above |
| P/B Ratio | 17.4 | 4.0 | Above |
| Dividend Yield | 2.2% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
280.73
vs
Market Price
460.28
Upside
-39.0%
| Margin of Safety | -64.0% |
| Stage 1 PV (5yr FCF) | 36,812,405,491 |
| Terminal Value PV | 115,035,531,013 |
| Total Enterprise Value | 151,847,936,504 |
Assumptions
| Base FCF | 7,464,578,535 |
| Growth Rate (5yr) | 8.5% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
41.39%
Full Kelly
20.7%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 63/100. Estimated win rate 59%, avg win 8.8%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
4
Bullish Signals
0
Bearish Signals
60.43
RSI(14)
14.2016
MACD
Relative Strength (RS) STRONG RS
80
/ 99
RS Rating
✓ O'Neil PASS (≥80)
| RS vs SPY | ↑ RISING (+17.6% vs SPY 3M) |
| RS vs Sector | INLINE (Healthcare) |
| RS New High | ✓ RS at 3-month high Institutional accumulation signal |
| Sector Outperformance | -0.3% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
STRONG RS:
Top performer — outperforming the market and making new relative highs. Institutional accumulation likely.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 60.43 | NEUTRAL |
| Macd | 14.2016 | BULLISH |
| Ma Cross | 421.96 / 374.67 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 1.45x | NORMAL |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 483.99 |
| Bollinger Upper | 480.34 |
| SMA(200) | 374.67 |
| SMA(50) | 421.96 |
| SMA(20) | 443.16 |
| Current Price | 460.28 |
| Bollinger Lower | 405.99 |
| 52-Week Low | 312.39 |
| ATR(14) | 12.56 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
DISTRIBUTION C
Confidence
56%
Upthrust (potential)
Acc: 0.0 |
Dist: 2.5 |
Markup: 2.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-10-30 | Normal | 1.16x | Normal bar — no special VSA pattern |
| 2026-11-02 | Normal | 1.12x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.84x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.63x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.45x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 461.63 | Above Kijun |
| Kijun-sen (26) | 440.00 | Base line |
| Senkou A | 450.82 | Leading span A |
| Senkou B | 429.23 | Leading span B |
| Cloud | 429.23 – 450.82 | Bullish (Green) |
| Price vs Cloud | 460.28 | Above Cloud |
| Chikou Span | 407.27 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 405.99 – 480.34 | KC: 424.81 – 461.52
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 363.27
Anchor: 2025-11-05 (52w Low)
ABOVE AVWAP
+26.7%
Heikin-Ashi Trend
WEAKLY BULLISH
Full data via /api/advanced/AMGN
Valuation
| Metric | Value |
|---|---|
| Market Cap | 248.97B |
| P/E (TTM) | 26.68 |
| Forward P/E | N/A |
| P/B | 17.35 |
| EPS | 17.25 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 8.5% |
| Profit Margin | 24.1% |
| ROE | 78.4% |
| Debt/Equity | 376.30 |
| Current Ratio | 1.48 |
| Dividend Yield | 2.2% |
| Payout Ratio | N/A |
| Beta | 0.42 |
Trading Data
460.28
Open
460.28
Day High
460.28
Day Low
4.07M
Volume (1.5x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)